Scarica l'app Stockscreener
74.61
3.17%
-2.445
Dopo l'orario di chiusura:
73.90
-0.705
-0.94%
Precedente Chiudi:
$77.05
Aprire:
$76.51
Volume 24 ore:
246.27K
Relative Volume:
1.99
Capitalizzazione di mercato:
$498.55M
Reddito:
-
Utile/perdita netta:
$-7.12M
Rapporto P/E:
-32.44
EPS:
-2.3
Flusso di cassa netto:
$-6.82M
1 W Prestazione:
-7.18%
1M Prestazione:
-9.66%
6M Prestazione:
+120.59%
1 anno Prestazione:
+207.65%
Intervallo 1D:
$73.63
$76.89
Intervallo di 1 settimana:
$73.63
$83.86
Portata 52W:
$21.00
$105.00
Monopar Therapeutics Inc Stock (MNPR) Company Profile
Nome
Monopar Therapeutics Inc
Settore
Industria
Telefono
(847) 388-0349
Indirizzo
1000 SKOKIE BLVD SUITE 350, WILMETTE
Confronta MNPR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
74.61 | 514.89M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-11-10 | Iniziato | Leerink Partners | Outperform |
| 2025-10-13 | Iniziato | Barclays | Overweight |
| 2025-09-09 | Iniziato | BTIG Research | Buy |
| 2025-09-03 | Iniziato | Oppenheimer | Outperform |
| 2025-09-03 | Iniziato | Raymond James | Strong Buy |
| 2025-08-26 | Ripresa | H.C. Wainwright | Buy |
| 2025-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-23 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-19 | Ripresa | Piper Sandler | Overweight |
| 2025-01-10 | Iniziato | Piper Sandler | Overweight |
| 2024-10-11 | Iniziato | Rodman & Renshaw | Buy |
| 2021-01-28 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Monopar Therapeutics Inc Borsa (MNPR) Ultime notizie
Monopar Therapeutics (NASDAQ:MNPR) Upgraded at Wall Street Zen - Defense World
Aug Catalysts: How interest rate cuts could boost Monopar Therapeutics Inc stockGap Up & High Accuracy Trade Alerts - moha.gov.vn
Monopar Therapeutics (NASDAQ:MNPR) Shares Up 6.3%Should You Buy? - MarketBeat
Monopar Therapeutics (NASDAQ:MNPR) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Will Monopar Therapeutics Inc. stock benefit from commodity prices2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
Will Monopar Therapeutics Inc. (1IY0) stock rise with strong economyShare Buyback & Free Weekly Watchlist of Top Performers - Newser
How Monopar Therapeutics Inc. (1IY0) stock behaves in tightening cyclesJuly 2025 Setups & Consistent Growth Equity Picks - Newser
Is Monopar Therapeutics Inc. (1IY0) stock a safe buy pre earningsJuly 2025 Gainers & Verified Technical Signals - Newser
How (MNPR) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Monopar Therapeutics (NASDAQ:MNPR) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
How Monopar Therapeutics Inc. (1IY0) stock correlates with oil markets2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Can Monopar Therapeutics Inc. (1IY0) stock stage a strong rebound this quarterRecession Risk & Risk Controlled Stock Alerts - Newser
Is Monopar Therapeutics Inc. (1IY0) stock worth buying before Fed actionMarket Activity Report & High Accuracy Investment Signals - Newser
Is Monopar Therapeutics Inc. stock a safe investment in uncertain markets2025 Support & Resistance & Entry Point Strategy Guides - moha.gov.vn
Monopar Therapeutics Inc Stock Analysis and ForecastContrarian Investment Ideas & Free Rapid Portfolio Appreciation - earlytimes.in
Monopar Therapeutics (NASDAQ:MNPR) Shares Down 4%Time to Sell? - MarketBeat
What dividend safety score for Monopar Therapeutics Inc. stockNew Guidance & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Is Monopar Therapeutics Inc. stock a safe haven asset2025 Fundamental Recap & Weekly Breakout Watchlists - BỘ NỘI VỤ
Monopar Therapeutics (NASDAQ:MNPR) Shares Gap UpHere's What Happened - MarketBeat
Monopar Therapeutics Unveils Promising Phase 2 Study Results - MSN
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments - ADVFN
Trading Systems Reacting to (MNPR) Volatility - news.stocktradersdaily.com
Monopar Therapeutics Inc. (MNPR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is There An Opportunity With Monopar Therapeutics Inc.'s (NASDAQ:MNPR) 46% Undervaluation? - simplywall.st
Is Monopar Therapeutics Inc. (NASDAQ:MNPR) Trading At A 46% Discount? - Yahoo Finance
Monopar Therapeutics Shares Surge in Volatile Friday Session - Ad-hoc-news.de
Is Monopar Therapeutics Inc. stock a top momentum playTrade Signal Summary & Safe Entry Trade Signal Reports - newser.com
How geopolitical tensions affect Monopar Therapeutics Inc. stock2025 Institutional Moves & Growth Focused Investment Plans - newser.com
Will Monopar Therapeutics Inc. stock outperform Dow Jones indexMarket Volume Report & High Win Rate Trade Tips - newser.com
Why Monopar Therapeutics Inc. (1IY0) stock could be top winnerJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Why millennials buy Monopar Therapeutics Inc. (1IY0) stock2025 Support & Resistance & Free Fast Gain Swing Trade Alerts - newser.com
How Monopar Therapeutics Inc. (1IY0) stock expands through international marketsJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
Can Monopar Therapeutics Inc. stock sustain market leadershipJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
What moving averages say about Monopar Therapeutics Inc.Weekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
How Monopar Therapeutics Inc. (1IY0) stock reacts to monetary easingQuarterly Portfolio Summary & Growth Oriented Trading Recommendations - newser.com
Monopar Therapeutics Inc. stock prediction for this week2025 Pullback Review & Risk Controlled Daily Plans - newser.com
Is Monopar Therapeutics Inc. (1IY0) stock attractive for growth fundsJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
Will Monopar Therapeutics Inc. (1IY0) stock sustain dividend payouts2025 Trading Volume Trends & Weekly Top Gainers Alerts - newser.com
Monopar Therapeutics Inc Azioni (MNPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Monopar Therapeutics Inc Azioni (MNPR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tsuchimoto Kim R | Director |
Jul 14 '25 |
Sale |
40.00 |
8,904 |
356,171 |
11,486 |
| STARR CHRISTOPHER M | Director |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
5,173 |
| Robinson Chandler | Chief Executive Officer |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
73,472 |
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):